Robert B. Truitt
President and CEO, Ash Access Technology
United States of America
Mr. Robert B. Truitt, also known as Bob, Co-founded Ash Access Technology, Inc. in 2003 and serves as its Chief Executive Officer and President. Mr. Truitt Co-founded HemoCleanse, Inc., and serves as its President and Chief Executive Officer. He serves as the Chief Executive Officer and President of Ash Medical Systems, Inc., which is a subsidiary of HemoCleanse. He was General Partner of Indiana Growth Fund I, Ltd. He served as a Consultant with Truitt and Associates. From 1967 to 1982, he served at the Allen-Bradley Company, Rostone Division, where he started as a Project Engineer in 1967 and served as its President since 1974. He served as the President and Chairman of Renal Solutions, Inc. From 1963 to 1965, he served as Space Guidance Analyst, Apollo Project at General Motors. He serves as Chairman of Zurex PharmAgra, Inc. He Co-founded and served as Chairman of ZS Pharma, Inc. He served as the Chairman of Zurex Pharma, Inc. He has been Director at Western & Southern Financial Group, Inc. since May 11, 2017. Mr. Truitt serves as a Director of Zurex Pharma, Inc., HemoCleanse, Inc., and Ash Access Technology, Inc. He serves as Member of Advisory Board of NouvEau Inc. He served as a Director of ZS Pharma, Inc. until May 5, 2014. He holds a number of affiliations and honors and is a holder of three patents. Mr. Truitt received MS and BS degrees in Engineering Science from Purdue University and an MBA from Harvard University.
Business and Management